Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure
Christie Joya, Anuradha Ganesan(Walter Reed National Military Medical Center), Christina Schofield(Madigan Army Medical Center), Ryan C. Maves(Naval Medical Center San Diego), Robert Deiss, Brian K. Agan(Henry M. Jackson Foundation), Seung Won(Henry M. Jackson Foundation), Jason F. Okulicz(Gilead Sciences (United States)), Karl Kronmann(Naval Medical Center Portsmouth), Tahaniyat Lalani(Henry M. Jackson Foundation)
Cited by 110
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176